KLR Investment Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $231K | Sell |
7,785
-125
| -2% | -$3.71K | 0.17% | 166 |
|
|
2023
Q4 | $229K | Buy |
7,910
+249
| +3% | +$7.21K | 0.17% | 171 |
|
|
2023
Q3 | $278K | Sell |
7,661
-270
| -3% | -$9.78K | 0.25% | 135 |
|
|
2023
Q2 | $238K | Sell |
7,931
-30
| -0.4% | -$902 | 0.2% | 162 |
|
|
2023
Q1 | $288K | Sell |
7,961
-1,893
| -19% | -$68.6K | 0.25% | 131 |
|
|
2022
Q4 | $351K | Buy |
+9,854
| New | +$351K | 0.29% | 113 |
|